AI platforms that absorb trial data reconciliation could compress operations toward a small, accountable team.

Growing investment in agentic AI and workflow modernization signals that the industry is finally starting to treat payment ...

In this video interview, Patrick Mizer, chief technology officer at Ledger Run, describes how agentic AI is being applied to invoice processing—one of the most labor-intensive bottlenecks in site ...

AI is reshaping clinical research faster than any technology before it; but for sponsors and CROs, adoption without GxP-grade ...

How connected workflows can improve visibility across participant activity, treatment allocation, eCOA compliance, and supply status. Why oncology studies illustrate the growing need for integrated ...

In today's ACT Brief, we examine where agentic AI delivers immediate wins in site payments, how botanical therapies can earn ...

The FDA has issued a discussion paper outlining potential approaches to regulating generative artificial intelligence (GenAI) ...

He closed by connecting payment infrastructure directly to the broader site access problem, noting that with 80% of sites ...

AI is reshaping clinical research faster than any technology before it; but for sponsors and CROs, adoption without GxP-grade governance, validation, and human oversight isn't a strategy. It's a risk.

In today's ACT Brief, we examine how payment reliability has become a competitive differentiator at high-performing sites, ...

In a recent video interview with Applied Clinical Trials, Patrick Mizer, chief technology officer at Ledger Run, discussed how payment reliability has quietly become one of the mo ...

In this episode of Beyond Compliance, Otis Johnson, PhD, MPA, founder and principal consultant at Vantix Operations, speaks with Joel Stanley, CEO of AJNA BioSciences, about why botanical therapies ...